2[1]Aguiar T. Therapy-related chronic myeloid leukemia:an epidemiological,clinical and pathogenetic appraisal. Leukemia and Lymphoma, 1998,29(1-2): 17-26. 被引量：1
3[2]Lois B,Travis JK,Rochelle EC, et al. Leukemia following lowdoes total body irradtiom and chemotherapy for non Hodgkin's lyphoma. J Clin Onco1,1996,14(2) :565-571. 被引量：1
4[3]Yuii T,Takeshi H,Kouzin K,et al. Leukemia is developing after treatment for thyroid cancer in a patient with Werner's sydrome:Molecular and cytogentic studies. Internal Medicine, 1995,34 (9):863-867. 被引量：1
5[4]Felix CA,Hosler MR,Winick NJ,et al. A11-1 gene rearangements in DNA topoisonerase Ⅱ inhibitor-retated leukemia in children. Blood, 1995,85(11): 3250-3260. 被引量：1
6[5]Wanders J, Wattendorff AR, Endtz, LJ, et al. Chronic myeloid leukemia in Myasthenia Gravis after long-term treatment with 6Mercaptopurine. Acta Med Scand, 1981,210(3) :235-238. 被引量：1
8[2]Castagnola C. Nozza A. Corso A. The value of combination therapy in adult myeloid leukemia with central nervous system involvement[J]. Heamatologica,1997,82(5):577-580. 被引量：1
9[3]Stewart DJ. Keating MJ. Mecnedie KB. et al. Natural history of central nervous systemy acute leukemia in adults[J]. Cancer,1981,47(1):184-196. 被引量：1
